S&P Global Ratings anticipates that ModivCare will fall short of its previous expectations for 2024 and 2025, leading to ongoing cash flow deficits. The company's reliance on normalized utilization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback